Piperacillin, Tazobactam: Powder for solution for injection (2.25g)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
What is this Medicine?
PIPERACILLIN; TAZOBACTAM (pi PER a sil in; ta zoe BAK tam) is a penicillin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.
Piperacillin/Tazobactam 2.25g Powder for Injection
NDC: 007813110-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Peritonitis, Pneumonia, Intraabdominal Infections, Intraabdominal Abscess, Nosocomial Pneumonia, Diabetic Foot Ulcer, Pelvic Inflammatory Disease (PID), Cellulitis, Skin And Skin Structure Infections, Endometritis, Appendicitis, Lower Respiratory Tract Infections, Community-acquired Pneumonia
Sometimes used for but not FDA approved for the following conditions:
Bacteremia, Febrile Neutropenia, Pyelonephritis, Cystic Fibrosis, Septicemia, Urinary Tract Infection (UTI), Surgical Infection Prophylaxis
Reconstituted product is stable for up to 24 hours at room temperature and 48 hours under refrigeration
Store unreconstituted product at 68 to 77 degrees F
Reported Side Effects for Piperacillin/Tazobactam 2.25g Powder for Injection
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: RAPID
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: RAPID
Onset: EARLY
Onset: EARLY
Onset: RAPID
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Compatible - This drug is generally safe to take by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


